the Thanks, Please start Lynne. today. to call X. joining Hi, Thanks Slide for everyone.
sheet. highlights a few financial balance cover the Let’s with starting
the fiscal cash activities million during payment during compared for the of Bonuses bonuses quarter was early XXXX the usage XXXX for increase year. XXXX. to was in $X.X employee not company’s cash net for operating usage fourth net previous are The and to XXXX due for paid $X.X million XXXX. million for primarily year in operating as Our $X
expenses the benefited savings compared we of $XX.X guidance range cost net XXXX. cash, timing certain the fourth securities. We fourth favorably will the that equivalents we cash tests with in million and million to recorded million. quarter the and operating of In first quarter short-term from $X.X Our of field in of $X.X additional related usage cash quarter, some the the provided XXXX to ended captured be
on no In addition, we issued costs on able and offering of of direct were raising be to X.X this shares March We net warrants. million XX, $X.X registered closed million to offering, a common price market with approximately stock. pleased at our operating
range XXXX million as For million. net we range expect $X.X of had usage similar for we cash in $X a XXXX, in the to approximately
directing generating traits. will yield points, investment and advancing working of We proof into development be our collaborations in that
continue to have on our We balance no sheet. debt
current to together We quarter XXXX. to operations government our number our revenue cash points support our of on from a expected expect the technology fourth of proof with hand grant into
were were applicable XXXX. fourth to now In quarter Let’s year and end of research of per net compared $X.XX per at operating quarter million development on results. the quarter or share common of $X.XX and of million net shareholders XXXX $X.X consistent $X.X XXXX expenses million XXXX to to Total quarter a of the $X.X of loss for XXXX. in This share and fourth of the million the or quarter research were reported and development fourth and $XXX,XXX. loss fourth XXXX, operating research operating million the The company quarter in G&A of review $XXX,XXX. fourth $X.X a of expenses compares grant revenues fourth of the for $X quarterly expenses G&A
$X.XX dividend XXXX issued stock years operating XXXX a of was to XXXX. revenue a full accounting $X.X a $X.X previous for $X.X the $X.X and which or million, with expenses deemed grant XXXX for loss to financing. our million XXXX the includes research $X.XX compared million for XXXX, XX, company’s per to a $X.X net December net up ending year per in related XX, compares for convertible adjustment operating XXXX connection XXXX. the year. share, and million ended for in a development December million A from of Total $XXX,XXX $X.X in of recorded in $XXX,XXX preferred million the expenses million Research were G&A respectively. conversion company year For beneficial December recorded the the were share and Series compared XXXX reported loss $XX.X loss feature to
details on to results, refer please For our more release. financial the earnings
our have here. seed the X Slide of goals to tolerance Sherri in novel I to to in the advisor commercialization team focus the and added early a and review is I the each recent in our successfully former number named commercial of traits knowledge YieldXX highlights traits. yield assessment significant company field our Technical plant We an like executive, and key our to and Commercial program we XXXX would invaluable increase resource evaluate science, terrific to key initiated objectives a and mention as did XXXX. Sherri’s Monsanto in – Advisor. a our Brown, job very ability Dr. turn let’s of landscape Sherri Special that to Brown corn on extensive our am background development on drought for our We accomplishments. of Now, team. executed achieve yield to and proud her of making the We enhance in
test the publishing highest announced from Some CXXXX seed know Based canola to We our may in XXXX phase results canola of these lines sector of address XX% the best the you in by of XXXX. the CXXXX seed producing gene on of field we of that in is increases corn to far States. United tested. into results, development plan commercial yield up the in value
results continuation yield chamber of This of trait research the as XX% containing agreement growth and announced Camelina. XXXX. the with support We granted compared continued best is Camelina promising revalued plants. to plants to more for our vigorously Monsanto/Bayer CXXXX controlled in conducted the of our develop to license for research soybean. studies seed in lines up grew using increases produced CXXXX CXXXX yield We
field XXXX. in these plants will test We
Our of O'Lakes a license novel strengthening CXXXX on executed Forage worldwide X agreement research signed in subsidiary to CXXXX X University license platform. edible oils our We technologies, the non-exclusive a Land Missouri option yield and novel traits significantly of evaluate our and company International, with Genetics gene sorghum. to exercise forage exclusive with
Biotechnology the at oil observations metabolism of also our of new around advisory focused targets biochemistry and Missouri inventory We University to scientific are to Jay is fundamental Regulative this regulated BRS, We to generating BRS of gene-edited technology, high of regulations. biosynthesis confirming the are sativa from his oil named Jay under us. the oil Camelina response Biochemistry content our of on Thelen, plant positive triple the increased Professor developed Dr. improve not a Services, interest lines board. using for received that CRISPR-CasX USDA-APHIS’
research signed CRISPR-CasX jointly have Pioneer, Institute Agriscience, Broad Harvard a of We the DowDuPont crops. and Division the technology and of agreement with use part nonexclusive for of genome-editing MIT license for Corteva the Ag of
to for have we beyond. focus said, we out made XXXX will we key laid milestones on of the XXXX in are I and progress As continue the significant and corporate proud achieving
a capabilities ag. popular and exemplify phase as on presence XXXX value Let’s In creation. build our timeline YieldXX and and we innovation now to the our X to emerging company. as our CRISPR articles Slide and our referred investor XXXX of turn credibility on path through of the relationships we presentations in These Monsanto Genetics ag leading media as with and goals Forage YieldXX and
will we in crops. a development we enter XXXX, what increased focus to as in major growing phase, XXXX During of refer commercial traits
trait their evaluate transcription traits. a of yield embraced a on rapidly platform deploy novel was clarified new on the generating XXXX to way CXXXX, CXXXX use in to vision started into the based of global bear crop second as to the bring When of XXXX, and and system the license a new to yield and the to crops. metabolic traits our During the January, new in engineering solutions YieldXX, technologies. find celebrated and Success traits security. YieldXX will started this YieldXX lead CRISPR-CasX rapidly In into platform phase our our we research XXXX testing We XXXX, in our as phase, yield skills a harvest and biology and as developing brought we In included In to technology Camelina there we increasing and unique we are also for factors food capabilities picture and a our us assets commercial new core anniversary of improving we as U.S. CRISPR series crop tool executed traits. beyond. in it for Bioscience. genome-editing partnerships regulatory in synthetic genome-editing revenue address on with emphasis the
over in points provide soybean, third-parties. us studies crops resources deploying such proof and investment traits crops to driven traits own Camelina data way to in of affiliations certain time with U.S. XXXX/XX, leveraging also first we we are traits plus traits key to us crops. and will of cleared the XXXX, of period, development observations through we data transition possible corn, new as in expect commercial the USDA-APHIS, formed and traits to generated time pipeline for enable of through on two our by key our we data the have activity XXXX our rich wheat primarily In generation XXXX, exciting form affiliations from and this our end we studying more. to the and in rice. our as a generate a made our During also By had test key we from collaborations working of testing In canola, in revenue that
our Slide affiliations crops. in talk expand X Let’s testing to turn traits now key of about the to to
the commercial ag are and license of YieldXX the traits. In of a Forage signed Crop In late germplasm, we of in testing CXXXX resources Science well the enabling commercial the with XXXX, field on Bayer to work test to performance and underway. CXXXX expertise soybean. with partner provide to data research Monsanto, industry signed Genetics and the XXXX, we our traits We and leaders X collect of licensing is research Forage license traits fast in evaluation leveraging for deploy them yield sorghum non-exclusive
the pleased lines. with have progress CXXXX made very considerable they elite in their soybean deploying are We
their data, in test the we to that As come commercial companies respective strategy, to traits obtain negotiate their at areas they these target provided crops part expectation our promising to data license. yield in our their licenses the can non-exclusive of and if they cost with generate with startup us
into traits major or we before work generate With respect discussions. engaging and corn, deploy ag the major more in crops corn soybean, engaged licensing to data in are our collaborative North understand of to company the a to and America our corn value preferences underway. For that traits is to definitive, have
wheat, data we In genome-edited we to at will data, working and based including collaborations are and researchers to NRC XXXX, on our Canada CXXXX on revenue continue rice of activities in generate with generating more setting as For for develop evaluation wheat. for lines stage traits, our our in the including field canola, focused crops, traits. series
Let’s to discuss turn American the opportunities. to X sector Slide now seed North
North yields. The years, in both herbicides where and ag input XX last corn has been stacked and Canola in and soybean, also canola, The and traits tolerance. plus for engineered herbicide pests, traits been these designed have result America the a Over into and now have majors soybean the provided to with investments have corn as to protect North traits deployed made America. South the resistance seed dominate cotton market traits the market essentially in largest dominate insect deployed crops. biotech
being yields are we working have large which in traits These these crop seed with impact acres. an controlled compatible acres the of these more to by for million number staple a Historically, commercial foods regulatory. for global major a and much on crops traits these and to Wheat can will reasons, of pipeline American a all seed the The is about estimated rice We for ag cover is We is XXX improve believe wheat of majors of the rice than and and crops. million XX are applicable North in population. crops. rice cultivated globally. not supply be it X inherent acres wheat million
wheat using align able and So approaches perceptions these improvements with and should a we in commercial crops meaningful opportunity, space on consumer where focusing to by preferences to represent be genome-editing bring of CRISPR white rice. yields
points as and Forage provide update these be sorghum. Dr. acres sorghum turn in opportunistic an crops other proof and our a for North And represent players with licensing combined Kristi? in Forage feed our dairy alfalfa have Genetics can we Kristi used America. we are expect traits These around specialty I and partnering on opportunities that XX activities traits. Snell area novel where just for work we with cows to to livestock. million with and the It’s will generating novel now many us will on call in pipeline. crops an done
